drugset / Trial / NCT05084196
Melatonin for Prevention of Kidney Injury
RandomizedParallel-groupDouble-blindPrevention
Summary
This study will evaluate the safety and effectiveness of melatonin for the prevention of antibiotic associated acute kidney injury in hospitalized patients.
Timeline
- Start
- 2023-06-05
- Primary completion
- 2027-06-01
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melatonin | Small molecule | 5 mg | Oral |